Search research articles
Contact Us
Filters
Showing results (271-280 of 315) with videos related to
Page
of 32
Sort By:
Haematologica
|
July 6, 2014
Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study
Khaled M Musallam, Maria Domenica Cappellini, Shahina Daar, et al.
American Journal of Blood Research
|
November 29, 2023
The efficacy of <i>Allium ampeloprasum</i> L. in reducing neutrophil recovery time in childhood cancer with febrile neutropenia: a randomized, double-blind, placebo-controlled trial
Mohammadreza Bordbar, Mehdi Vahidifar, Mohammad Mehdi Zarshenas, et al.
Annals of Hematology
|
November 20, 2020
Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
Sezaneh Haghpanah, Nader Cohan, Mohammadreza Bordbar, et al.
European Journal of Internal Medicine
|
November 15, 2011
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
Mehran Karimi, Khaled M Musallam, Maria Domenica Cappellini, et al.
Prenatal Diagnosis
|
August 22, 2015
Effectiveness of β-thalassemia prenatal diagnosis in Southern Iran: a cohort study
Mohamad Moghadam, Mehran Karimi, Seyed Javad Dehghani, et al.
Pediatric Endocrinology Reviews : PER
|
April 25, 2012
Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011)
Vincenzo De Sanctis, Ahmad Elawwa, Michael Angastiniotis, et al.
Blood
|
December 25, 2009
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
Ali T Taher, Khaled M Musallam, Mehran Karimi, et al.
Blood Advances
|
April 9, 2024
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort
Shermarke Hassan, Guido Baselli, Luca Mollica, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 14, 2021
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A
Shermarke Hassan, Roberta Palla, Carla Valsecchi, et al.
Transfusion
|
December 2, 2017
Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial
Toshko Lissitchkov, Bella Madan, Claudia Djambas Khayat, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 315) with videos related to
Sort By:
Page
of 32
Haematologica
|
July 6, 2014
Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study
Khaled M Musallam, Maria Domenica Cappellini, Shahina Daar, et al.
American Journal of Blood Research
|
November 29, 2023
The efficacy of <i>Allium ampeloprasum</i> L. in reducing neutrophil recovery time in childhood cancer with febrile neutropenia: a randomized, double-blind, placebo-controlled trial
Mohammadreza Bordbar, Mehdi Vahidifar, Mohammad Mehdi Zarshenas, et al.
Annals of Hematology
|
November 20, 2020
Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
Sezaneh Haghpanah, Nader Cohan, Mohammadreza Bordbar, et al.
European Journal of Internal Medicine
|
November 15, 2011
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
Mehran Karimi, Khaled M Musallam, Maria Domenica Cappellini, et al.
Prenatal Diagnosis
|
August 22, 2015
Effectiveness of β-thalassemia prenatal diagnosis in Southern Iran: a cohort study
Mohamad Moghadam, Mehran Karimi, Seyed Javad Dehghani, et al.
Pediatric Endocrinology Reviews : PER
|
April 25, 2012
Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011)
Vincenzo De Sanctis, Ahmad Elawwa, Michael Angastiniotis, et al.
Blood
|
December 25, 2009
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
Ali T Taher, Khaled M Musallam, Mehran Karimi, et al.
Blood Advances
|
April 9, 2024
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort
Shermarke Hassan, Guido Baselli, Luca Mollica, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 14, 2021
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A
Shermarke Hassan, Roberta Palla, Carla Valsecchi, et al.
Transfusion
|
December 2, 2017
Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial
Toshko Lissitchkov, Bella Madan, Claudia Djambas Khayat, et al.
Page
of 32